Clinical leads play a key role in developing clinical trials in specific disease areas, as outlined in the table below. Our clinical leads works closely with the CR-UK Clinical Trials Unit, which will coordinate relevant expertise to translate scientific concepts from bench to bedside, and works with the National Health Service, with industry and with academic departments across the UK and internationally. This could include novel therapeutic concepts or new uses for established treatments.
For general enquiries to the CRUK Clinical Trials Unit about new trials, email email@example.com or phone +44 (0) 121 414 9247.
For disease-specific trial queries, contact the appropriate clinical leads from the tables below.
CIIC OVERALL CLINICAL TRIAL LEADS
|Professor Charlie Craddock||Haematological Malignancies|
|Professor Gary Middleton||Solid Tumours|
CLINICAL THEME LEADS
|Professor Charlie Craddock||Director, SCT Unit, Queen Elizabeth Hospital Birmingham; Member, NCRI AML Subgroup; Chief Investigator, LLR Therapy Acceleration Programme|
|Professor Paul Moss||Member, NCRI Haematological Oncology Clinical Studies Group|
|Professor Gary Middleton||Member of NCRI Lung Cancer Clinical Studies Group|
|Professor Dion Morton||NCRI Colorectal CancerClinical Studies Group, former Chair of Surgical subgroup; Head of Research Committee, Royal College of Surgeons|
|HEAD AND NECK CANCER|
|Professor Hisham Mehanna||Chair, NCRI Head and Neck Cancer Clinical Studies Group|
|LIVER INFLAMMATION AND CANCER|
|Professor David Adams||Head, NIHR Birmingham Liver BRU|
|Dr Ye Oo||Member, NIHR Birmingham Liver BRU|
|Dr Neil Steven||Deputy Clinical Director, CRCTU; Head of Early Phase Adult Solid Tumour Trials, CRCTU|
|Dr Rik Bryan||Member, NCRI Bladder Cancer Clinical Studies Group; Chief Investigator of the Bladder Cancer Prognosis Programme (BCPP)|